Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from C-MER Eye Care Holdings Limited ( (HK:3309) ).
C-MER Medical Holdings Limited has announced a significant increase in profit for the first half of 2025, with expected profits ranging from HK$46.0 million to HK$52.0 million, marking a 49% to 69% increase compared to the same period last year. This growth is attributed to a slight revenue increase and strategic measures to enhance operational efficiency, such as closing non-performing operations and implementing cost-saving strategies.
The most recent analyst rating on (HK:3309) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on C-MER Eye Care Holdings Limited stock, see the HK:3309 Stock Forecast page.
More about C-MER Eye Care Holdings Limited
C-MER Medical Holdings Limited operates in the healthcare industry, focusing on eye care services. The company is known for its network of eye care centers and is committed to optimizing its service offerings and operational efficiency.
Average Trading Volume: 829,223
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.37B
Learn more about 3309 stock on TipRanks’ Stock Analysis page.